Literature DB >> 11522327

Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system.

Z Rogóz1, G Skuza, D Dlaboga, J Maj, M Dziedzicka-Wasylewska.   

Abstract

Tianeptine (TIA) is an antidepressant drug which enhances the reuptake of serotonin but, in contrast to tricyclics, shows no affinity for neurotransmitter receptors. The present study was aimed at determining whether repeated TIA treatment induced adaptive changes in the alpha(1)-adrenergic system, similar to those reported by us earlier for tricyclic antidepressants. The experiments were carried out on male mice and rats. TIA was administered at a dose of 5 or 10mg/kg once or repeatedly (twice daily for 14 days) and fluoxetine (FLU), used as a reference compound, at a dose of 10mg/kg. The obtained results showed that TIA administered repeatedly potentiated the methoxamine- and phenylephrine (PHEN)-induced exploratory hyperactivity in rats and clonidine-induced aggressiveness in mice, the effects mediated by alpha(1)-adrenoceptors. TIA given repeatedly (but not acutely) increased the binding (B(max)) of alpha(1)-adrenergic receptors in cerebral cortex for [(3)H]prazosin. However, the ability of the alpha(1)-adrenoceptor agonist PHEN to compete for these sites was not significantly changed. The above results indicate that repeated TIA administration increases the responsiveness of the alpha(1)-adrenergic system (behavioural and biochemical changes). On the other hand, FLU did not affect any behavioural and biochemical changes in this system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522327     DOI: 10.1016/s0028-3908(01)00079-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Metabolomic profiling relates tianeptine effectiveness with hippocampal GABA, myo-inositol, cholesterol, and fatty acid metabolism restoration in socially isolated rats.

Authors:  Ivana Perić; Marija Lješević; Vladimir Beškoski; Milan Nikolić; Dragana Filipović
Journal:  Psychopharmacology (Berl)       Date:  2022-07-01       Impact factor: 4.415

2.  Tianeptine in combination with monoamine oxidase inhibitors for major depressive disorder.

Authors:  Edward H Tobe
Journal:  BMJ Case Rep       Date:  2012-10-09

Review 3.  The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies.

Authors:  Maria Carrillo; Lesley A Ricci; Glen A Coppersmith; Richard H Melloni
Journal:  Psychopharmacology (Berl)       Date:  2009-04-30       Impact factor: 4.530

4.  Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine.

Authors:  Elizabeth A Pekarskaya; Emma S Holt; Jay A Gingrich; Mark S Ansorge; Jonathan A Javitch; Sarah E Canetta
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

Review 5.  The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.

Authors:  B S McEwen; S Chattarji; D M Diamond; T M Jay; L P Reagan; P Svenningsson; E Fuchs
Journal:  Mol Psychiatry       Date:  2009-08-25       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.